Šilalės vaistinės - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 279,483 | 266,589 | 247,456 | 301,062 | 405,103 | 460,654 | 541,209 | 287,590 |
| Profit before tax | -89 | 7,768 | 7,924 | 7,313 | 9,667 | 21,092 | 11,925 | 10,740 |
| Net profit | -99 | 7,418 | 7,567 | 6,983 | 9,230 | 20,143 | 11,388 | 10,740 |
| Equity | 10,469 | 17,887 | 25,454 | 32,437 | 41,667 | 61,810 | 73,198 | 83,938 |
| Liabilities | 119,986 | 116,469 | 105,102 | 133,853 | 134,517 | 124,742 | 127,680 | 72,718 |
| Non-current assets | 69,674 | 67,675 | 64,722 | 89,170 | 86,712 | 85,445 | 84,640 | 116,784 |
| Current assets | 60,781 | 66,681 | 65,834 | 76,786 | 89,124 | 100,713 | 115,840 | 39,791 |
| Total assets | 130,455 | 134,356 | 130,556 | 165,956 | 175,836 | 186,158 | 200,480 | 156,575 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 7,929 | 107 | 13,088 |
| Social insurance contributions | - | - | - | - | - | 14,887 | 17,975 | 10,736 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -31.7% | -4.6% | -7.2% | +21.7% | +34.6% | +13.7% | +17.5% | -46.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -0.1% | 5.5% | 5.8% | 4.2% | 5.2% | 10.8% | 5.7% | 6.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -0.9% | 41.5% | 29.7% | 21.5% | 22.2% | 32.6% | 15.6% | 12.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.0% | 2.8% | 3.1% | 2.3% | 2.3% | 4.4% | 2.1% | 3.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.0% | 2.9% | 3.2% | 2.4% | 2.4% | 4.6% | 2.2% | 3.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 11.5 | 6.5 | 4.1 | 4.1 | 3.2 | 2.0 | 1.7 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 30,769 | 38,084 | 35,351 | 43,009 | 57,872 | 65,808 | 77,316 | 70,431 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Šilalės vaistinės - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2021-11-16 | 2021-11-23 | 0.24 |
| 2021-11-05 | 2021-11-14 | 0.24 |
Šilalės vaistinės - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-29 | 2025-05-29 | 0.01 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Šilales vaistines, UAB (code 176525521) is a private limited liability company engaged in the retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of €287.6K and net profit of €10.7K, which corresponds to a profit margin of 3.7%. Revenue declined by 46.9% year on year and was 37.6% below the 2023 level, after peaking at €541.2K in 2024 from €460.7K in 2023. Profitability remained positive throughout the period, although net profit decreased from €20.1K in 2023 to €11.4K in 2024 and €10.7K in 2025. At the end of 2025, total assets stood at €156.6K, equity at €83.9K and liabilities at €72.7K, giving an equity ratio of 53.6% and a debt-to-equity ratio of 0.87. Return on equity was 12.8% and return on assets 6.9%, while asset turnover reached 1.84x. Revenue per employee was €71.9K, with profit per employee of €2.7K.